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~fuen thr.bce-washed red cells are aggluti nat ed by rabbit ant i - human-
globulin-sera (Coombs reagent), t hey are said t o be "coated11 with an 
"incomplete" (blocking) antibody.l Such coating occurs in vivo in 
erythroblastosis fetalis as a result of placental transfer of maternal 
iso-antibody, and in ac~uired hemolytic anemia of t he immunologic 
variety;c ( 11auto-i!lllllune" hemolytic disease 3, 4) as a result of unknm..n 
mechanisms. It may also occur in vitro, by exposure of red cell 
suspensions t o antisera containing blocking ant ibodies of the appr opr1ate 
specif1ci ty. 
Despite the sensitive serologic methods 1, 2, 5, 6 now available 
for the detection of the "incomplete" antibody bound to t he erythr ocyte 
1. Coombs, R. A., Mourant, E. E. , and Race, R. R.: New Test for detection 
of weak or 11incomplete 11 Rh agg.mtinins . Bnt. J • .l:!;xper . Path., 
26: 255, 1945. 
2 . Boorman, K. E., Dodd, B. E., and Loutit, J. F. : Haemolytic ictarus 
(acholuric j aundice); congenital and acquired . Lancet, 1 : 812, 
1946. 
3. Young, L. E. and Miller, 
hemolyti c disease. 
G.: The l ong t erm picture i n auto-immune 
Trans . A. Am. Phys . 66: 190, 1953 . 
4. a. Dameshek, W.: Acquired hemolytic anemia . Physiopathology, with 
p~rticular reference t o autoimmunization and therapy. Proc . 
Th1rd Int. Congress Int. Soc. Hem~tology, Cambridge, Heinemann, 
p. 120. 
b. Rosenthal , M. C., Pisciotta, A. V., Kooninos, Z. D., Goldenberg, H., 
and Dameshek, W.: The aut o-immune hemolytic anemia of malignant 
lymphocytic disease. Blood, 10: 3, 1955. 
5. Neber, J., and Dameshek, W.: I mpvoved demonstration of c1rculating 
antibodies in hemolytic anemia by use of bovine albumin . Blood, 
2: 371, 1947 . 
6 . Morton, J . A. and Pickles, M. M.: Use of trypsin in detection of 
incomplete antibodies . Nature, 159: 779, 1947. 
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surface in "auto-immune" hemolytic disease, stud~ of the nature of this 
"erythrocyte-coating-substence" has been greatly impeded bJi the difficulties 
inherent in obttining significant amounts of this m£.terial free of 
contamination by serum proteins or red cell stromata. This report 
deals with studies of the coating substance eluted from the red cells 
of ''auto-immune" hemolytic disease, "'ith particular reference to possible 
differences in serolog~c properties of the "erythrocyte-coating-substance" 
(ECS) in idiopathic arid symptom&tic* "auto-immunetr hemolytic disease 
and in cases with warm as contrasted with "cold" auto-antibodies. 
Materials and Methods 
1. Clinical mc..terial (Tables I and II) 
Eluates were prepared from the erythrocytes of l4 patients 
with "auto-immune" hemolytic disease, 10 with "warm" auto-antibodies 
end 4 with auto-antibodies of the "coldtr variety. In some cases, serial 
eluates were prepared before, during, £.nd after s teroid ther~py. The 
red cells in all cases displayed both a 41 direct anti-globulin (Coombs) 
reaction at the time of eluate preparation and a decreased life-
span as measured by chromium5l_(Cr51) red cell survival studies 
* Symptom&tic "auto-imnnme" hemolytic disease is defined as auto-immune 
hemolytic disease secondary to such diseases as leukemia, lymphoma, 
neoplasm, collagen disease (7, ~). 
7. Singer, K., and Dameshek, W.: Symptomatic hemolytic anemia. Arch. 
Int. Med., 15: 544, 1941. 
8. Wasserman, L., Stats, D.,Schwartz, L., and Fudenberg, H. Symptomat~c 
and hemopathic hemolytic anemia. Amer. J. Med. 18; 961, 1955. 
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Control eluates were also prepared from normal erythrocytes, from 
Rh~ erythrocytes coated i n vitro wi t..ll a potent anti-Rho anti-::;erum, 
and from t he erythrocytes of 8 patients with diverse hematologic 
malignancies but with negative serologic tests for "auto-immune" 
hemolytic disease. In these latt er 8 cases , anemia and decreased 
erythrocyte survival tlme, as demonstrable by chromium5l_red cell 
survival studi es , were present. 
2. Eluate prep~ation 
Elution was carried out by a quant i t ative modification of 
the method of Kidd .9 The elution method was rigidly standardized in 
an attempt to obtain a relatively constant proportion of the total 
amount of coating substance in each case. After removal of t he 
plasma fron 500 ml. of citrated whole blood, the erythrocytes were 
divided into four equal aliquots and wasned six t imes in 250 cc. 
centrifuge cups. In these cases with "warm" antibodies, washing was 
carried out at 40 C. with flve-fold volumes of cold sal~ne ; in t he 
cases with "cold" incomplete antibodies, t wo of t he four ali quots 
were washed with cold saline and two with warm saline (370 C. ). 
The supernatant obtained following the sixth washing was tes ted by the 
indi r ect globulin method to insure absence of traces of residual plasma 
antibody . The erythrocytes were then ~sed in a 10-fold volume of slightly 
9 . Kidd, P. : Elution of an incomplete type of antibody from the 
erythrocytes in acquired hemolytic anemia . J. Ci in. Path., 
2: 103, 1949. 
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acidified (lxlo-4 M HAc) distilled water and lysis further insured by 
freezing and thawing. Stroma was precipita ted by adjusting the pH of 
tne mixture to 5. 7 with 0 .l N HCl. The precipitate was removed by 
centrifugation and washed six times with cold M/15 phosphate buffer, 
pH 5.7 to facilitate removal of hemoglobin (and other hemochromogens). 
Two of the four preparations containing ''cold11 auto- antibody were 
washed with buffer at 37oc. The final stromal preparation was White 
to slightLy gray in color. 
The packed residual stroma preparation, appr oximately 4% of the 
original volume of packed erythrocytes, was centrifuged in graduated 
centrifuge tubes, the supernatant removed, and a 2.5-fold volume of 
citrate-HCl buffer, pH 3.3, added. After rapid mixing, the prl of the 
mixture w&s adjusted to 3.3 by the dropwise addition of 1 N HCl; only 
a few drops were necessary. 
The mixture was kept at 25° C. for 15 minutes. The stromat a were 
then separated by centrifugation at 3000 rpm for 6 minutes at room 
temperature; the supernatant was then removed and its pH rapidly 
adjusted to 7 . 2 by the addition of 5 N NaOH (0 . 01 by volume, plus a 
few additional drops when needed) . The stroma precipitate formed during 
neutralization was then removed b,y centrifugation at room temperature 
and the colorless supernatant eluate stored in sealed screw-cap vials 
at -20° C. Sodium azide, 0.25%, was used as a preservative. 
The eluates from the red cells coated with 11warm11 antibodies were 
tested for antibody activity prior to and subsequent to storage by 
-5 
exposing 2% saline suspensions of thrice-washed p ooled 0 kh negative 
erythrocytes t o equal volumes (usually 0. 1 ml.) of serial dilutions of 
each eluat e. 'With eluates from cases with "cold" incomplete antibodies, 
tests were performed against both saline ar.d fresh serum suspensions of 
washed pooled 0 Rh negative erythrocytes. 
3. Coombs (anti-globulin) serum 
Standard anti -globulin sera were prepared b,y the int ramuscular 
injection of mixtures of nor mal human serum and Freund adjuvant-* into 
rabbits weighing 4 kilograms. Booster doses of hum&n serum without 
adjuvant ~ere given at 14 and 24 days, and the Coombs sera harvested 
at 31 days. Anti-sera Rl8 and Rl9 were prepared against human ~era 
obt~ined from normal donors. Anti-ser a R 21-28 were prepar ed against 
sera obtai ned from patients witn malignant hematologic diseases (e.g. , 
leukemia , lymphoma) without evidence of 11 auto-immune" hemolytic disease 
despite diminished red cel l survival time (as measured by cr51- erythrocyte 
half-life) . Coombs sera Rel 8, 9, 10, and 11 were prepar ed b.Y intravenous 
inj ection of rabbi ts weighing 4 kilograms with eluates obtained from the 
erythrocytes of pati ents with 11 auto- i mmune" hemolytic disease, idiopathic 
in etiology i n 2 cases (Rel 8 , 9) , and secondary to chronic lymphocytic 
leukemia and lymphosarcoma in R6 1 10 and R61 11, respectively.** R 12 
was prepared in s. simill;J' manner, using alum-precipi t c.ted human gll.liii!ls. 
globulint as the &ntigen. To avoid ~ disproportionete respon~e to 
* Obtai ned from Difco Labor~tories, Detroit, as Bacto-Adjuvant . 
** Both cases hG.d "warm'' auto-antibo~·. Repeated attempts. to proc~uce anti-
globulin serE:.. by immuniz.ation with eluates from :.:. cases of ''auto-immune' 
hemolytic disease of the cola vt..riety were unsuccessful. 
t Fraction II 1, ~ ( 99% gamma globulin by moving boundary electropltoresi~ ) 
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weaker , cross-reacting antigens, ~·reund adjuvant wss not used in 1:.he 
preparation of Rel 8-11. The rabbits were injected f our times weekly 
for four weeks, using the immunization schedule of Kabat ana Bezer.lO 
The rabbit anti-sera were harvested by intracardiac puncture. Aliquots 
of each anti-serum were saved for precip~t~n tests. The remainder of e~ch 
serum W6S diluted 1 : 10, heat inactivated ~t 56° C. for 15 minutes, tmo 
absorbed with washed pooled normal A, B, A~B, and u cells. The anti-sera 
were diluted to com~srable potency after parallel titration in block against 
Rh~ erythrocytes co~. ted With serial dilutions of anti-Rh0 anti-serum.ll 
4. Eluate Total Prote~n Nitroge~ Concentration 
These were estimated bf the biuret raaction.l2 
5. Precivitin Te~ts 
Precipitin tests were performed by adding 1 . 0 cc. of various 
anti-globulin sera to 4.0 cc. of eluate. This w~s followed by incubation 
for 1 ho,~ at 37° c., refrigerEtion for 48 hours at 40 c., nnd centrifugat1on 
at .3000 rpm for 1 hour e.t 4° C. Prccipi tc.te~ \:ere H.shed three times in 
chilled saline. The eluate "anti-elobulin rPacti ve'' l'CS nitrogen concentra-
tions were estimeted by the Lowryl.3 method efter corrparison 'Hi th stance.:rd 
curves calibrated by readings obtained upon the addition of known runounts 
lC. Kab~t, E. A., end Bezer, A.: Personal communication. 
11. National Institutes of Health. t>iinimum ReLJ,uirements: Anti-human 
serum for the Anti-Globulin Test. Publication, Department Health, 
Education and Welfare, May 10, 1949. 
12. Levin, R., and Brauer, R. W. : Tne biuret reaction for the determination 
of patterns--an improved reagent and its applicat1on. J.Clin. 
Lab. Med., 38: 474, 1951. 
13. Lowry, 0. H., Rosebrough, N.J., Farr, A. L., and Randall, R. J. : Protein 
measurement with the Folin Phenol Reagent. J. Biol. Chem., 193: 
265, 1951 
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of gamma globulin to 1.00 cc. of anti-globulin serum. Supernatant fluids 
in all reaction tubes were tested for the presence of free antiGen and 
free antibody. 
6. Preparation of Standard Eluates 
Eluates 8, 9, 10, and 11 were titrated in parallel versus a 
2% saline suspension of pooled 0 cells by the indirect Coombs method, 
using anti-globulin sera R 18 and 19. Titers obte~ned from eluates 8, 9, 
10, and 11 were 10,240, 2,56o, and 1,280 respectivel y. Eluates 9 and 10 
were therefore appropriately diluted to obtain s tandard titers of 1,280. 
7. Red Cell Survival 
Apparent erythrocyte half-life was measured by tne Cr5l* 
method as modified by Donahue et al.l4 
8. Electrophoretic analyses 
Electrophoretic analyses** of the proteins of tne sera of 
patients and of normal controls were carried out by t he method of Bernfeldl5 
in a 2.5 ml. Tiselius cell of a Perkin-Elmer model 38 apparatus. The 
original protein buffer boundary was displaced 9 mm. into the limb of the 
cell and photographically recorded by me~s of the Longsworth sc&nning method. 
The protein boundaries after exposure t o an electri c fi eld of 10.5 volts/em. 
* 1' Rachro!'late", Abbott Laboratories, Chicago. 
** We are indebted to Dr. Peter Bernfeld, Tufts Uni versi t) School of Medicine, 
for these determinations. 
14. Donahue, D. M., Motulsky, A. G., Gibblett, E. R., Pittio-Biroli, G., 
Vtranuvatti, V., and Finch, C. A.: The use of chromium as a redcel l 
tag. Brit. J. Haem., 1: 249, 1955. 
15. Bernfeld, P., Donahue, D· M., snd Homburger, F.: Char acterist ic 
individual electrophoretic patterns in hWIIBlls . Proc. Soc. ];xp . Biol. 
Med., New Yor4, 83: 420, 1953. 
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(130 volt difference of potential between t he two electrodes) for 70 minutes 
wer e photographed on the same film. 
Results 
l. Eluate reacti vity 
Seventeen eluates obtained from the erythrocytes of 10 putients 
antibody 
with "warn" 'b.uto-immune" hemolytic disease gave positive results when tested ,... 
by the indirect Coombs method wi. th anti-globulin sera R 18 ana Rl9 . Tests 
with eluates obtained fron the erythrocytes of four normal (control) donors , 
wi. th eluates from the erythrocytes of four cases of "auto-immune 11 hemolytic 
disease witn cold antibody and from the erythrocytes of L~ p~tients wi~~ 
van.ous hematologic malignancies 'Hi thout "auto-immune" hemolytic disease 
(Table I) gave uniformly negative results. 
Positive precipitin tests were obtained with six "warm" eluates but 
no "cold" eluates (Table II) . 
2 . Effect of differential ~bsorption of Coombs sera on reactivity. 
Aliquots of Rl8 and Rl9 were absorbed with ( ~) normE..l human 
serum: (b) serum from a patient vith congenital agammaglobulinemia;* 
(c) buffered solution of r'raction II 1 ? (99% gw:!L'Ila globulin, by moving ,-
boundar;}· electrophoresis)·** Each aliquot was then used in precipitin 
tests with the six "warm" eluates with which positive precipitin t ests 
were obtained with unabsorbed anti-globulin sera. Fesults of precipitin 
* Dr. David Gitlin, Children's Me~cal Center, Boston, most generously 
supplied this . 
** A gift from Dr. Robert B. Pennell, Protein Foundation, Inc., Boston . 
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tests ~th native and absorbed antisera Rl8 are listed in Table III. 
Iaentlcal resul ts were obtaineCl with simib.rly absorbed aliquots of Rl9 . 
3. Relation of ECS concentration to disease severity 
The erythrocyte survival time, as measured by cr51 -red 
blood cell apparent half-li fe , appeared inversely related to the quantity 
of ECS present in t."te eluate of each patient with "auto-immune" hemol:,- tic 
disease (Table I). Of tne six eludtes containing sufficient ECS to 
give visible precipitin reactions, onl~ four formed enough precipit~te to 
permit measurement of anti-globulin-reactive ECS ni tro~en b;r the biuret 
and Lowry methods. 1'ven in these f our cases, the colorimetric readings 
obtained were at the extreme end of the curve, so tha t the estimated results 
are in error by perhaps 25%. However, they do indicate tne order of magni-
tude of "antibody" nitrogen in the eluate. i•1oreover, the ratio of antibody 
aitrogen to totel nitrogen in these four cases is &pproxim~tely the same 
(0.3%), suggesting that relative~ constnnt proportions of t he totel amount 
of ECS were removed in each case ~· the standardized elution method 
used (Table IV). 
4. Similarity of specificity in the ECS of idiopt thic and symptomb.tic 
hemolytic anemia 
Electrophoretic an~lysis disclosed unusual patterns (double 
gamma, alpha~ ,and hypo ga!lli!laglobulinemi"" p.s.tterns) in severu of the 
idiopathic cases. F~gu.res I-II. . Such p~tterns were not 
observed in the symptomatic cases Fig . Il~; Attempts to deMonstrate 
preferential specificity of anti-sera versus idiop~thic ECS (e.g., Rel 8 , 9) 
against erythrocytes coated with eluates idiopathic from rea cells of 
idiopathic cases (eluates 8 and 9), ana of anti-6era to symptomatic ECS 
{Rel 10, 11) against erythrocytes coated with symptomt..tic ECS (eluates 10,11) 
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were unsuccessf\ll . Tests in parellel with anti-serum Re18 against 
eryt.1.rocytes coated wi t..t'l stands.rd eluates 8 , 9 , 10 and 11 gave identical 
end-points (Tatie V). Similar results were observed with anti-sera 
Rel 9, Re110 and Re111 (Table VI). 
The use of eluates 8, 9, 10 and 11 in anti-globulin inhibition tests 
gave partial inhibition in dilutions 1: 2, 1:4, and 1:8 , and proved 
ineffective in greater dilutions. The four eluates gave essentially 
identical results in such tests, regdrdless of the eluate used for 
coating or ~~e anti-serum used. 
5. Serol ogic investigations of hem~tologic malignancies. 
Eight anti-globulin sera (R 21-?~ ) prepared using serum from 
patlents with various hematologic malignancies (anti-H. M.-globulin sera) 
failed to produce positive reactions when tested by the indirect Coombs 
method against normal red cells coated ~~th previously rep~red el uates 
from t..~e H. M-globulin'donors. Uniformly negative results were also 
obtained when these anti-bera were used in direct "anti-H . M. -globulin 
tes.ts" against the erythrocyte of 6-10 patients with each disease entity. 
The subjects tested all displ~yed moderate t~ marked anemia, reticulo-
cytosis (3-8%l and negative Coombs tests using the usual t ype of anti-
globulin serum. However, tne anti-H. !.f . -sera gave positive resul t s in 
each ins t ance in which positive res~ts were demonstrab l e qy the use of 
Coombs sera prepared fro~ normal serum donors . (Table VII). 
Discussion 
The nature of the "erythrocyte-coating-substar'lce" (ECS) responsible 
for tne positive anti-globulin (Coombs) react ion in acquired hemolytic 
anemia remains obscure. This and other lt:~.boratories have ma.J.ntained that 
the substance is an auto-antibody directed against the patient ' s 
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erythrocytes,3, 4,16 and that this auto-antibody is directly implicated 
in the pathogenesis of the hemolytic state . However, this concept is 
by no means universally accepted. l ?-20 
Understanding of the 11 erythrocyte-coating-substance 11 has been 
hampered by difficult y in obtaining suff1 cien t quantities of the rna terial. 
Attempts to correlate t he severity of the hemolytic process with tne 
quantity of 11 antibody11 presumably pr esent in a given case have been 
generally unsuccessful , Most attempt s t o measure concentration of 
erythroc.yte-bound antibody nave been based on results of titration of 
anti-globulin sera, the end-poi nt being t he greatest dilution of anti-
globulin sera producing a positive direct anti-globulin (Coombs) reaction. 
Such methods, encompassing the non- linear range of antigen- antibody 
16. Dausset, J . et Teysseire, Y. Etude evolutive de 30 cas d1 anemie 
hemolytique acquise avec auto-anticorps chauds . Transfusion 
sanguine et actual ites hematologiques . Paris, Masson & Cie. 
pp. 306-311, 1954. 
17. Wagley, P. F., Shen, S. C., Gardner, F. R. , and Cantle, W. B: 
Studies on the destruction of red blood cel ls , VI. J . Lab. Clin . 
Med., 33: 1197, 1948. 
18. Ponder, E.: A study of the anemia occurring in the tumor-bearing 
mice of the C3d str ain, Revue d 1Hemat. , 9: 562, 1954. 
19. Samaille, S.: Proc. Fifth International Congress of Internt..tional 
Society of Hematology. Les Anticorps anti- hemolytique (cteseles) 
per la directa reaction le Coombs au cours des anemias 
emperimentales par injection d ' hetere et d 1 isqimmune serum. 
20 . Wi tebsky, E.: The immunology of acquired hemol;:,rti c anemia: 
Diagnostic and therapeutic considerations, Proc . Fourth Int. 
Congress Int. Soc. of Hemat., Mar del PLata. Grune and S~ratton , 
New York, 1954. 
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inter action, and i ncluding the range of antigen excess, are bused on 
obviously err oneous assumpt ions21 and ar e cited only to be condemned. 
~uantitutive expressi on (1 to 4,L) of the degree of positivitj of the 
dir ect anti - gl obulin (Coombs) r eaction is of lit tle ~d, since in most 
cases the dir ect Coombs r emains s t rongly posit1ve for many mon~~s after 
marked clinical i mprovement has been produced by steroid administration . 22, 2.3 , ~J 
However, use of ser ial dilut ions of ECS e~uted f r om the erythrocyte 
stromata by semi-quant1tative techni~ues , in co~bin~t1on with co~stant 
amounts of Coombs anti-~lobulin ser a (ineffect anti- ECS sera) of 
sufficient strengtn to pr ovide antibody excess, provides an immunologically 
sound method of measuring r elat i ve amounts of the erythrocyte bound 
coat ing subst ance. I n such a r eaction mixture , the ECS funct ions as 
the ant igen and t he anti-globulin serum as the antibody. 
The f inding that the antigen nitr ogen/total protein nitrogen ratio 
was r elatively constant in the four eluates in which the antigen (ECS} nitrogen 
was measurable af for d support f or the assumpt ion th~t tne rigidly 
21. Kabat, E. A., and ~'J:ayer , M. M.: Experimental Immunocnemistry. 
C. C. Thomas, Spr ingfield, Illinois , 1951. 
22. a. Dameshek, W. : Haema.tologi cal application of ACTti and corti sone, 
Br i t. J . r.fed. , 2: 612, 1952. 
b . Dameshek , W. and Kornninos, Z. D. : Tne present status of treat -
ment of aut oimmune hemolytic anemia wi t~1 ACTH and Cortisone . 
Blood 11, 648 , 1956. 
2.3. Dacie, J. V. : The hemolyt1c anemias, Grune and Stratton, New York, 1954. 
24. Clear kin, K.: Effect of adrenocorticotropic hormone on clinical 
and experimental hemolytic anemias. Lancet: 1: 18.3, 195~ . 
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standardized elution method employed did indeed remove a relatively 
constant amount of ECS in each instance. 
Based upon the above assumption, ~~e quantity of ECS present in 
each case was well correlated w~th the degree of hemolysis, as measured 
by diminution in cr51 -erythrocyte apparent half-life (Table II). 
Quantities of ECS sufficient to produce visible precipitin reactions were 
present only in those cases in which the erythrocyte survival time was 
most severely shortened. Furthermore, quilitative estimates of magnitude 
of precipitin reaction were in general inverseiy related to erythrocyte 
life span. Indeed, the four cases with the greatest diminution of ery-
throcyte life-span were the only ones in which the amount of ECS antigen 
nitrogen was sufficient to warrant measurement by quantitative methods. 
It is thus evident that the severity of the hemolytic process is indeed 
closely related to the concentration of erythrocyte-bound coating substance. 
The findings of simultaneous progressive diminution in ECS concentration 
during the progressive increase in cr5l-erythrocyte life-span during 
steroid therapy in four cases of "auto-immune" hemolytic disease with 
"warm" antibodies ( 'l'able II) are further evide!lce of t he cl ose interrelation-
ship between the ECS concentration and the severity of the disease 
process. It is realized that a cause-and-effect relationship r at her than 
an interrelationship does not necessarily follow, although highly 
suggestive from the above data. However, demonstration of a cause-
and-effect relationship would undoubtedly furnish strong support for the 
protagonists of the "auto-immune" etiology of acquired hemolytic anemia. 
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Since cortisone h~s been shown by many~5, 26, 27, 28 to decrease 
antibody production, the diminution in concentration of ECS follo>ang 
steroid administration, with the concomit&nt increase in er~ythrocyte 
life-span, does indeed suggest that the ECS is an antibody, as does the 
demonstration that the Coombs-re~ctive ECS nitrogen is bound to the 
erythrocyte stroma, and can be separated from the stroma by st~~d&rd 
techni~ues for antibody-antigen dissociation.9 The result of precipitin 
tests using anti-human-globulin sera absorbed with aga~maglobulinemic 
and normal human sere suggest& the.t the ECS in "warm" auto-immune 
hemolytic disease is a gumma globulin, or at least has cross-re4ctivity 
with gamma globulin . These findings confirm impressions gained by 
other investigators, using less reliable agglutination inhio~tion 
r ather than precipitin inhibit~on methods.29, 30 Attempts to ch&racterize 
25. a . bjornboe, M., Fischel, E. E., and Stoerk, H. C. : The effect of 
cortisone and adrenocorticotropic hormone on the concentration 
of circulating &ntibody. J. Exper . Med., 93 : 37, 1951. 
b . Fischel, E. E., Stoerk, H.C., Bjornboe, M. : Failure of cort~sone 
to affect rate of disappearance of Wltibod~ protein. Proc . 
Soc . Exp. ~iol. and Med., 88: 111, 1954. 
26. Germuth, F. G., Oyama, J., and Ottinger, G. J •: The mechanism of 
action of 17-hydrox~-11 dehydro corticosterone (Compound E) 
and of the adrenocorticotropic hormone in experimenta~ 
hypersensitivitl of rabb~ts . J. Expcr . Med ., 94: 139, 1951. 
27. Fischel, E. E. In the effect of ACTH and cortisone upon infection 
28. 
and resistance. Ed . b,y G. Schwartzmann, Columbia Univ. Press, 1953. 
Kaliss, N., Hoecker, G., and Bry~nt , B • F.: The effect of cortisone 
on isohemagglutinin production in mice . J. Immunol , 76: 83, 1956 . 
Decie, J. V. Acquireo hemolytic anemia. 
the entiglobulin (Coombs ' ) reaction. 
With special reference to 
Blooa, 8: 813, 1953. 
30. Cutbush, M., ~rawford , H., and Moll~son, P. L. Observations on 
anti-human globulin ser a . Brit. J. Haem. , 1 : 410, 1955. 
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the ECS as to its immunologic similarit~ or difference froffi the more 
usual variety of serum gamma globulins using agar diffusion methods3l 
ar e now in progr ess and will be reportea elsewhere . Demonstr ation of 
t he gamma globulin character of the ECS is of mor e t han academic interest 
in view of t he similar nature of most antibodies . However, i n contrast 
to other erythrocyte pan-antibodies, e . g ., saline cold hemagglut1nins, 
t be "auto-entibodies 11 of auto-immune hemolytic disease display both 
species and ~ntigen specificity. Although t he saline cold hemPgglutinin 
nonspecifically agglutin£tes the er,ythrocytes of all humans and of various 
mammalian species,32, 33, 34 the antibodies of "auto-immune" hemol;ytic 
anemia react only w~th human red cells, i.e., display spec1es specificity.35, 36 
In addition, t he use of panels of red cells of varying antigenic composition 
31. Oudin, J. in "Methods in Medical Resecrch", vol. 5, p. 335, Yeurbook 
Publ ishers , Chicago, 1952. 
32. 
33. 
Clough, M. C. and hichter, I. 
occurring in a. human serum. 
M. h study of an auto-aggl utinin 
Bull . Johns Hopkins Hosp . ~9 : 86, 1918 . 
Turner, J. C. and Jackson , ~ . B. 
anti body in a typical pneumoni&. 
Serologi cal specificitJ' of an auto-
orit. J . Exp . Path . 24, l~l, 1943. 
34. Wiener, A. J., Gordon, E. B., and Gall up, C. Studies on au.-OOantibodies 
in human sera . J. lmmunol. 71: 58, 1953. 
35 . Sturgeon, P. A new antibody- in serum of patients w~ th acquired hemolytic 
anemia. Science 108: 293, 1947. 
36. Komninos, A. D. , and Rosenthal, M. u. Studies on sntibodies eluted 
from the red cells in auto-immune hemolyt1c anemia. J. Leb. 
and Clin. Med. 41: 887, 1953. 
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has demonstrated that eluates obtuned from the red cells of a vtient 
with 11 auto-immune" hemolytic disease often possess preferent~al specificity 
for one or another of the blood group antigens present in the red 
cells of the donor p~tient,37-40 i.e., auto-specificity. If the pre-
V1.ously propounded evidence for the antibody nature of the ECS in 
"auto-immune" hemolytic d~seaseis accepted, the fincii.ngs of preferential 
specificity against blood group factors present in the patient's own 
red cells do indeed strongly suggest th~t the disease is auto-i~~une 
in nc.ture, at least in the "warm" cases. 
Since the eluates from the cases of "cold" auto-immune hemolytic 
disease failed to give positive precipitin tests, failec toproduce 
ant~-elobulin serum, and indeed failed to react by indirect-Coombs 
method with sal ine or fresh serum suspensions of pooled red cells , tne 
assumption by previous workers 16, ~ , 23, thet the "coating subotance" 
in "cold" auto-immune hemolytic disease is an entibooy merits reevaluation. 
Our findings suggest that the "coating substance" in the "cold" auto-immune 
37. Weiner, W., Battey, D. A., Cleghorn, T. E., Merson , F. G. w., and 
Meynell, M. J. Serologic findings in a case of hemolytic anemia. 
Brit. M. J. 2: 125, 1953. 
38. Dacie, J. V. and Cutbush, rot. 
acquired hemolyt~c anemi£.. 
Specificitl of auto-antibodies in 
J. Clin. Path. 7: 18, 1954. 
39. von Lognem, J. J. and van der Hart, M. V&rieties of auto-antibodies 
in acquired hemolytic anemia . Vox Sanguinis 4: ~, 1954. 
40. Crowley, L. V. and Bouroncle, B. S. Studies on the specif~city 
of auto-antibodie~ in acquired hemolytic anemie. Blood 11:700, 1956. 
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hemolytic ~sease cases is, inste~d, an adsorbed protein !~eking ant~body 
characteristics and not amenable to separation from the stroma by 
st~dard methods of antigen-antibody dissociation. These findings confirm 
objections to the "antibody" concept of the coating subst~ce in "cold" 
auto-immune hemolytic dise&se r£ised recentiy by Dacie41; this worker 
has provided evidence that the coating substance in such cases is 
complement adsorbed to the red ceil surface r~ther than ar.tibody. 
As previously noted, only a small percentage of the protein 
nitrogen present in the eluates gave positive precipitin test with 
Coombs (anti-globulin) serum. The nature of the non-Coombs-reectlve 
protein nitrogen remains obscure, as aoes tile nature of tne non-pro-r.ein 
nitrogen present . Invest~gations of pooled lyophilized eiuteQ m&terial* 
revealed ~ carbohydrate content eq~v~ent (by weight) to ~4% of tne 
tot~ protein content. Hexosamine comprised less than 15% of the total 
carbohydrates. Other ~ne sugars, pentoses, desoxypentoses, and uronic 
acid could not be identified. 
The large amount of non-CoombE-reactive prote~n nitrogen may resuit 
from a considerable loss of immunologic reactivit) of the ECS during 
the eluation process, without degradation of a degree sufficient to alter 
the biuret reaction. It is also :f-Ossible th&t the non-Coombs-reactive 
* We are indebted to Dr. Peter Hernfeld, Tufts Unive1sity School of 
Medicine, for these determinations. 
41. Dac,le, J. V., Crookston, J. H., and Christenson,~. N. Incomplete 
cold antibodies. Proc. Sixth Congress of the International Society 
of Blood Tr€nsfusion, ~oston, Sept. 3, 1956. 
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I 
protein is an enzyme derived from complement (C 1), similar to the 
esterase eluted from antigen-antibody aggregates oy Lepow et al , 42 
using pneumococcal specific soluble substance {Slii) and enti-SIII-rabbit 
sera . These latt er investigators noted enhancement of C I ester ase 
activit~ upon elev&tion of ~~e pH from 5.5 to 7.4. Stud~es on pooled 
lyophilized ''auto-immune" hemolytic disease elus.tes revealed a mE.rked 
decre~se in titer following dialJsis (at 4° C. ) at slightly alkaline pH, 
~athout decr ease in titer upon dial)sis at pH ranges from 3.2 to 5.5,12b 
also suggesting t he presence of a proteolytic enzyme active et alKaline 
pH, as a f actor contr~buting to the non-Coombs-reactive eluate pr otein. 
Others have specul&ted that positive anti-globulin tests in acquired 
hemolytic anemia. are non-specific manifestations not necessarily impli-
cated in the disease process, implying t hat the hemolysis is becondary 
to the hematologic malignancy per se in the symptomatic cases, and to 
unrecognized viral or chemical agents in the ''idiopathic" c~ses.l7-20 
Such speculations would be strengthened if differential specificity 
could be demonstrated between the idiopathic and "symptomatic11 cases. 
Observations of unusual serum globulin distribution patterns on moving 
boundary electrophoresis in three pati ents wi t n iaiopathic "auto-immune11 
42 . Lepow, I. H. , Ratnoff, 0. D., ana Pillemer, L. Elution of an 
esterase from antigen-antibod;y aggregates treated m th human comple-
ment. Proc. Soc. ~xp . Biol. and Med . 192: 11, 1956. 
43 . Bernfeld, P .: Personal communication. 
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hemolytic disease (Figs . I-II ) in conjunction with relatively normal 
electrophoretic patterns in 8 patients wi t.l1 11 symptomatic" auto-immune 
hemolytic disease (Fi.g •.III) also suggested t he possibility of differ-
ences in reactivity of the ECS in these two groups of cLses. However, 
indirect Coombs titration and inhibition tests using appropriate anti-
sera against cells coated with ECS obtained from idiopat hic and 
"symptomatic" cases of "auto-immune" hemol;ytic di sease disclosed no 
preferential specificity, a finding in keeping ~th our clinical obser-
vations as to the i dentity of the clinical manifestations in these cases . 
Anti-globulin (Coombs) sera prepar ed against the senun proteins of 
patients with various hematolog~c malignancies involving the antibod~y­
forming tissue (spleen, l ymph nodes , etc.) failed to give positive nirect 
or indirect Coombs tests in cases negative with tests using Coombs 
sera prepared against normal, rather thlill abnormal , human sera. These 
anti-sera wer-e produced to test the hypothesis that alteration of the 
reticulo-endothelie,l system,ie., the site of the body's antibody 
"factory", oy prolifer ative disease might conceivably result in !"ormation 
of abnormal serum proteins, with resultant incorporation of abnormal 
protein into anti-bodies coating the erythrocytes . Conceivably, 
standard normal Coombs anti-globu~in serum, directed against normal 
human globuli n, could fail to react with abnormal globulin coating the 
erythrocytes. However, the results obtained using Coombs ser a produced 
against serum obtained from pe.tients with reticulo-endothelial malig-
nancies , anemia, and di minished erythr ocyte survival differed in no wa:y 
from the results obt ained with the use of standard (anti-normal-human 
-20-
globulin) Coombs serum. Use of the former sera failed to demonstr~te 
erythrocyte-bound antibody in any instance when ECS -wa.s not detectable 
by stand~rd (anti-normal humun globulin) ~oombs anti-serum. 
Conclusions 
1. These observations indicate that the life span of the 
erythrocytes, measured in fourteen instances of "auto-
immune" hemolytic disease, -was inversely proportional 
to the concentre.tion of "erythrocyte ooating substance." 
2. Steroid therapy resulted in decrease in "erythrocyte 
coating substmce" concentration and concomi ta.nt 
increase in erythrocyte life-span. 
Indirect Coombs inhibition tests and precipitin and 
precipitin inhibition tests demonstrated that the 
11erythrocyte coating substance" in 11'Warm11 auto-immune 
hemolytic disease is either a gamma glob>..llin or a 
sut>sta.nce croes-reacting "With gamma globulin. The 
lacK of reactivity of the "erythrocyte coating substance" 
of "auto-immune'' hemolyt~c disease "With "cold11 
antibody suggests that i n this disease state the 
erythrocytes are coated qy an adsorbed protein lacking 
antibody characteristics. 
4. No difference in reactivitJ was observed in cases of 
11 auto-immune" hemol~t~c disease of the idiopathic and 
of the "symptomatic" ve.riety, despite unusual serum 
protein patterns obtained upon moving boundary electro-
phoresis in three cases of the idiopathic variety. 
5. Anti- serum prepc..red ago i nst the serum proteins of 
patients witn various hematologic oclignancies, anemia 
and Gecre~sec erythrocyte survival ~a neg~tlve 
serologic tests for 11 auto- immune 11 hemolytl.c disease 
failed to demonstrate erytnrocyte- bouna antibOQy in 
these cases . 
6. These flndings suggest ~.e un1t~r1an nature of all 
c&.ses of 11 ai.tto- immune1 nemolytic Cisease of t.""le 1'"'arm1 
variet.r, ~nd fur nish evidence for the 11 anti- body1' 
nature of tae 11 erytnrocyte-coat1ng-subst~ce' .Present 
i n tnib disease . The hernol;tic anemia of the ne~ctologi c 
m~ignancies ~th negative Coombs test is ~resum~b~y 












TJi.BLE I. Eluate A.cti vi t;y 
( by Indirect Coombs Te~t) 
RESULTS 
Condition R 18 
warm AIHD* 3/- to 41-
cole AIHD* 0 
chr. lymph . leuk.** 0 
chr. ~eyel. leuk.** 0 
lymphosarcoma*"* 0 
Hodgkinls dise~se** 0 
myeloma**-(H-type) 0 
myeloma*-* ( T'- type) 0 
Rh0 f cells coated with 31-
a.nti- Rh0 (1: 50) 
normal control 0 
saline control 0 
* Auto-Immune Hemolytic Disease 
** Plus anemie., reticulocytosis, guaiac 
negative stools, shortened cr51 
erythrocyte half-life, and negative 
-2~-
R ;;:1-:28*** 











ser ologic tests for auto-i mmune hemol tic disease. 
*** Each of these anti-bera used in 
indi1·ect Coombs test against 5 warm 
eluates, 2 cola e~uates, and 
ag~nst the eluate used in product-
ion of the given anti-serum . 
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TABLE IT. AUTO-IMMtf.NE HE.MOLY'l'IC DISEhSE: 
Relation of degree of hemolysis 
to the guantitl of erlthrocyte coating substance. 
Pt.# Disease Warm Steroid Serum Eluate 
Process or Rx Globulin RBC destruction 
Cold {mo.) Pattern precip. tot. antiglob. cr51 de st. 
test prot. reactive RBC T~ r ate (lf -4-f ) N protein N ( de.ys) t (x-
(mg/ (micgm/ norm. 
ml) ml) 
1 a idiopathic w pre-Rx 1 11creased f#- 0.324 1.08 5 15.0 . 
b 
" 
w 2 gamma I 0. 214 0.65 11 5.8 
c 
" 
w 6 0 0.019 
--** 20 2 . 4 
2 . a idiopathic w pre-R normal ff 0.302 0 .93 7 10.6 X 
b II w 2 0 0.069 16 3.4 
c 
" 
w 4 0 0 .049 20 2.4 
3. a idiopathic w pre-rsc decreased l.fl 0 .611 1.80 8 8 .6 
b 
" w 6 gamma f 0. 165 12 5.2 
c " w 10 0 0 .045 18 2 . 3 
4- idiopathic w pre-Rx: alphax 0 0 .0?8 16 3 . 4 
5. a 1ymphosarc. w 6 decreased 0 0 .038 15 3. 8 
b II 12 gamma 0 0.019 23 1.6 
6. 1ymphosarc. w 12 normal 0 0.030 17 3.1 
7. chr. lymph. w 6 marked by de- 0 0.051 18 2 .8 
leukemia creased gamma 
8. chr. lymph. w 9 normal 0 0 .037 21 2 . 2 
leukemia 
9. L.E. w 3 increased f 0.138 12 5.2 
gamma 
LO. L. E. w 6 incree.sed 0 0 .09ih 14 4 . 2 
gamma 
.1. idiopathic c pre-Rx double 0 . 147 14.5 4.0 
gamma 
.2. idiopathic c normal 0 0 . 069 17 3.1 
.3 . lymphosarc. c 3 normal 0 0.027 2.3 1.6 
.4. post-viralp pre-Rx normal 0 0 . 058 21 2 . 2 
pneum. 
*Donahue, D. M. et al (14). 
** No measurable reaction obtainable. t Chromium51 er.ythrocyte half-life (days). 
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TABLE IIA. AUTO-IMMUNE HE~OLYTlC DISE.hSE: 
Erythrocyte Coating Substance/Total Protein Ratio 
Eluate # Total protein N · Antiglobulin Ratio (mg/ml) reactive 
protein N 
ga.mma/ml 
l a 0 • .325 1.08 .3 • .32 lo-.3 
lb 0 .. 209 0.65 3.02 1o-3 
2a 0.331 0.93 2 .s2 1o-3 
3a 0.611 1.80 2.94 1o-3 
Aver age: 3.01 1o-3 
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TABLE III. Precipitin tests with 
Anti-human Globulin ~erum Rl8 
Eluute R 18 R l8a R l8b R 18c Control 
(non-absorbed) (absorbed (absorbed (absorbed rabbit 
with normal with agamma- w"l. th gamma serum 
ser um) globulinemic globulin) 
serum) 
la warm fff ff 0 fff ff 0 0 
lb warm ..L 0 I 0 0 I 
2a warm Hf ff 0 fff ff 0 0 
3a warm Hf 0 fff 0 0 
3b warm ff f 0 ff f 0 0 
9 warm f 0 I 0 0 
ll cold 0 0 0 0 0 
12 cold 0 0 0 0 0 
anti Rh0 -f 0 + 0 0 
saline 0 0 0 0 0 
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TABLE IV. A UTO-IMMUN1 HEMOLYTIC DlSE.hSE: 
ECS ~itrogen/Total Protein Nitrogen Ratio 




la 0.325 1.08 3 . 32 x lo-3 
lb 0.209 0 . 65 3 . o2 x lo-3 
2a 0 . 331 0 . 93 2.82 x lo-3 
3a 0. 611 1.80 2 .9 x lo- 3 
Averf..ge : 3 . 01 x lo-3 
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TABU, V. 
Indirect Anti-Globulin Test with P~ti-serum Re18 f~ainst 0 Rh-negative 
Er-tthrocytes Coated with Standard LluE:~tes* 





10 ~0 40 80 160 3~0 640 
41 41- 41 31 2!1 21 2,1 
LJ 11- 3l......l 2 I 3f 2~1 21. . :d- ltf 
41 4-l 3/- 3f 2f 2f l .t I 
4f 4/- 3~ 3-j 31 2f 2f 
* Eluate dilut eu to provide identical endpoints by 
indirect Coombs tes t with standard anti-globulin 











T.ABLE VI. Titer of Standard Eluates * 8-ll 
Using Anti-sera Re18-ll 
Eluat e: 8 9 10 
1280 1280 1280 
1280 1~0 2560 
1280 1280 1280 
640 1280 1280 
*Eluates diluted to provide identical end points 



















T/J:3U .. VIlL. 
Donor 
Chronic lymphc~tic l eukemia 
Chronic lymph&tic leukemia 
Chronic granulocytic leukemi& 
Chror.ic gr tnulocytic leukemia 
Lymphos&rcoma 
Hodgkin's disease 
Multiple myelom& (gc.mnu ... type) 
Multiple myelomc: (f>t type) 
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TABLE VIIB. Direct Anti-Globulin l'est 
_-~.sease Entity Pts. P..nti Serum Control 
tested R21 R22 R23 R24 R25 R26 R27 R28 R18 Sera (Commercial)* 
(Number of p~tients ~itn positive res~ts) 
Without AIHD** 
Chr. lymph . leuke- 10 0 0 0 0 0 0 0 0 0 0 
mie. 
Chr. gran. leukemia 7 0 0 0 0 0 0 0 0 0 0 
Lymphose.rcoma 7 0 0 0 0 0 0 0 0 0 0 
Giant follicle 6 0 0 0 0 0 0 0 0 0 0 
lymph oms. 
Hodgkin ' s dise~se 6 0 0 0 0 0 0 0 0 0 0 
Multiple ~eloma 5 0 0 0 0 0 0 0 0 0 0 
With ;.IHD** 
a. Idiopathic 5 5 5 5 5 5 5 5 5 5 5 
b. Symptomatic 
1. dis. lupus 
erythematosus 6 6 6 6 6 6 6 6 6 6 6 
2. chr. lymph . 
leukemia 5 5 5 5 5 5 5 5 5 5 5 
3. lymphoma 4 4 4 4 4 4 4 4 4 4 4 
4 · Hodgkin's 
disee.se 1 1 1 1 1 1 1 1 1 1 1 
* Ortho Laboratories, Rarite.n, N. J., Blood Grouping Laborator.j, Boston, M&ss ., 
Knickerbocker Biosales, Inc., N. Y., N.Y. 
** Auto-Immune Hemol~tic Disease 
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